JFG
NMRA icon

Jefferies Financial Group’s Neumora Therapeutics NMRA Stock Holding History

Jefferies Financial Group’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,300
Closed -$24.4K – 1874
2024
Q4 		$24.4K Buy
+2,300
New +$27.6K ﹤0.01% 1523

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return

Jefferies Financial Group's NMRA Position: Q1 2026 in Review

Jefferies Financial Group reduced its Neumora Therapeutics (NMRA) stake by 25% in Q1 2026, selling an estimated $29.1K and leaving 33,044 shares worth $64.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

Jefferies Financial Group first reported a position in NMRA in Q2 2024 and has held it in 5 quarters since. The position peaked at $319K in Q2 2024. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • Jefferies Financial Group held 33,044 shares of Neumora Therapeutics worth $64.4K as of Q1 2026.
  • Jefferies Financial Group sold 11,226 Neumora Therapeutics shares in Q1 2026, an estimated $29.1K.
  • Neumora Therapeutics made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1632 holding.
  • Jefferies Financial Group first reported a position in Neumora Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • Jefferies Financial Group's Neumora Therapeutics position peaked at $319K in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.